Article | May 25, 2017

A Call To Action: Industry Innovators Seek New Technologies To Advance Personalized Medicine

Source: Finesse, part of Thermo Fisher Scientific
Lonza and Atvio Biotech Seek New Technologies To Advance Personalized Medicine

Its precision in early disease detection and prevention offers the medical community a proactive way to treat patients, which could ultimately help control the overall cost of health care. It could also improve the quality of life for patients suffering from some of today’s most debilitating diseases.

Finesse, part of Thermo Fisher Scientific